Medi-Caps (NSE:MEDICAPQ) Cyclically Adjusted Revenue per Share: ₹0.00 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:MEDICAPQ Medi-Caps Ltd NSE:MEDICAPQ
41 GF Score
Price ₹23.56
GF Value ₹19.30
Valuation Modestly Overvalued
! 3 Warning Signs
View Full Analysis

What is Medi-Caps Cyclically Adjusted Revenue per Share?

Medi-Caps NSE:MEDICAPQ 41 Cyclically Adjusted Revenue per Share is ₹0.00 as of Jun. 2026. GuruFocus rates NSE:MEDICAPQ with a GF Score™ of 41/100 and a GF Value™ of ₹19.30 (Modestly Overvalued). The stock has 3 warning signs investors should review.

Note: As Cyclically Adjusted Revenue per Share is a main component used to calculate Cyclically Adjusted PS Ratio. If the month end stock price for this stock is zero, result may not be accurate due to the exchange rate between different shares and the data will not be stored into our database. Selected historical data showed in the calculation section below is only for demostration purpose.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Medi-Caps's adjusted revenue per share for the three months ended in Jun. 2026 was ₹2.178. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ₹0.00 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Medi-Caps's average Cyclically Adjusted Revenue Growth Rate was -4.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2026-08-20), Medi-Caps's current stock price is ₹23.56. Medi-Caps's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was ₹0.00. Medi-Caps's Cyclically Adjusted PS Ratio of today is .

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Medi-Caps was 1.18. The lowest was 0.52. And the median was 0.85.


Medi-Caps  (NSE:MEDICAPQ) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Medi-Caps was 1.18. The lowest was 0.52. And the median was 0.85.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Medi-Caps Cyclically Adjusted Revenue per Share Related Terms


Medi-Caps Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Medi-Caps's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medi-Caps Cyclically Adjusted Revenue per Share Chart

Medi-Caps Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Medi-Caps Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

NSE:MEDICAPQ vs : Cyclically Adjusted Revenue per Share Comparison

For the Real Estate - Diversified subindustry, Medi-Caps's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medi-Caps Cyclically Adjusted PS Ratio vs Real Estate Industry

For the Real Estate industry and Real Estate sector, Medi-Caps's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Medi-Caps's Cyclically Adjusted PS Ratio falls into.


NSE:MEDICAPQ
41GF Score
Medi-Caps Ltd NSE:MEDICAPQ
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medi-Caps Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Medi-Caps's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=2.178/333.9520*333.9520
=2.178

Current CPI (Jun. 2026) = 333.9520.

Medi-Caps Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201212 6.693 229.601 9.735
201303 7.079 232.773 10.156
201403 0.000 236.293 0.000
201503 0.000 236.119 0.000
201603 0.000 238.132 0.000
201703 0.000 243.801 0.000
201803 0.000 249.554 0.000
201806 6.324 251.989 8.381
201809 12.551 252.439 16.604
201812 10.677 251.233 14.192
201903 12.116 254.202 15.917
201906 12.654 256.143 16.498
201909 8.770 256.759 11.407
201912 6.759 256.974 8.784
202003 4.739 258.115 6.131
202006 13.243 257.797 17.155
202009 13.889 260.280 17.820
202012 14.567 260.474 18.676
202103 9.799 264.877 12.354
202106 13.751 271.696 16.902
202109 13.837 274.310 16.846
202112 13.855 278.802 16.596
202203 13.274 287.504 15.418
202206 9.925 296.311 11.186
202209 12.344 296.808 13.889
202212 8.746 296.797 9.841
202303 8.115 301.836 8.978
202306 4.980 305.109 5.451
202309 4.640 307.789 5.034
202312 5.482 306.746 5.968
202403 5.995 312.332 6.410
202406 4.969 314.175 5.282
202409 6.632 315.301 7.024
202412 3.215 315.605 3.402
202503 5.569 319.799 5.815
202506 2.146 322.561 2.222
202509 1.607 324.800 1.652
202512 3.419 324.054 3.523
202603 2.745 330.213 2.776
202606 2.178 333.952 2.178

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of ₹0.00 mean?
Medi-Caps (NSE:MEDICAPQ) has a Cyclically Adjusted Revenue per Share of ₹0.00 as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Medi-Caps and its competitors.
Is Medi-Caps' Cyclically Adjusted Revenue per Share too high?
Medi-Caps' current Cyclically Adjusted Revenue per Share is ₹0.00. Overall, Medi-Caps has a GF Score™ of 41/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Medi-Caps' Cyclically Adjusted Revenue per Share compare to ?
Medi-Caps' Cyclically Adjusted Revenue per Share of ₹0.00 can be compared against companies in the Real Estate industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Real Estate company?
A good Cyclically Adjusted Revenue per Share depends on the Real Estate industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Medi-Caps and its competitors. Medi-Caps's current Cyclically Adjusted Revenue per Share is ₹0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medi-Caps stock overvalued right now?
Based on GuruFocus' analysis, Medi-Caps (NSE:MEDICAPQ) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹19.30, compared to a current price of ₹23.56 — trading 22.1% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is ₹0.00. Medi-Caps' overall GF Score™ is 41/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Medi-Caps (NSE:MEDICAPQ), the current Cyclically Adjusted Revenue per Share is ₹0.00 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medi-Caps (NSE:MEDICAPQ) Overvalued in 2026?

Based on GuruFocus' analysis, Medi-Caps stock appears to be overvalued. The current stock price of ₹23.56 is trading 22.1% above its estimated GF Value™ of ₹19.30. GuruFocus considers Medi-Caps to be Modestly Overvalued.

Key valuation signals for NSE:MEDICAPQ:

  • Cyclically Adjusted Revenue per Share: ₹0.00
  • GF Value™: ₹19.30 vs. price of ₹23.56 (22.1% above fair value)
  • GF Score™: 41/100 with 3 warning signs

No single metric tells the full story. See the NSE:MEDICAPQ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medi-Caps Business Description

Comparable Companies
Other Exchanges 523144:India
Address 201, Pushpratna Paradise, 9/5, New Palasia, Opposite UCO Bank, Indore, MP, IND, 452 001
Medi-Caps Ltd is an India-based company engaged in the real estate business witch city centric developments by way of Strategic Land acquisition and developing the residential and commercial properties. Its project include Medicaps Business Park. The group has two segments namely, the Pharma Division, and the Real Estate Division. The majority of its revenue is generated from the Pharma Division.
41GF Score

Get the complete analysis for NSE:MEDICAPQ

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹23.56
Price
₹19.30
GF Value